✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
|Docket||See Plans and Pricing||Date Filed||2017-11-13|
|Court||District Court, D. Minnesota||Date Terminated|
|Cause||35:271 Patent Infringement||Assigned To|
|Jury Demand||Referred To|
|Patents||10,309,966; 10,624,965; 7,483,896; 7,829,309; 8,883,692; 8,883,838; 8,906,646; 8,992,896|
|Link to Docket||External link to docket|
Small Molecule Drugs cited in Niazi Licensing Corporation v. St. Jude Medical S.C., Inc.
Biologic Drugs cited in Niazi Licensing Corporation v. St. Jude Medical S.C., Inc.
|Date Filed||Document No.||Description||Snippet||Link To Document|
|2020-04-02||229||Order re: Appeal/Objection of Magistrate Judge Decision to District Judge||Bank of Batesville v. Ford Motor Co., 16 F.3d 965, 966 (8th Cir. 1994); see also Carmody v. Kansas City …; Arabian Agr. Servs. Co. v. Chief Indus., Inc., 309 F.3d 479, 483 (8th Cir. 2002); Trost, 162 F.3d at…, Inc. (St. Jude) for infringement of a single patent. Fact discovery for the case closed on September…damages expert, Brad Carlson, which addresses NLC’s patent-infringement damages estimate. St. Jude moved …that Dr. Burke directly infringed NLC’s method patent using St. Jude’s products, and on October 15, 2019||External link to document|
|>Date Filed||>Document No.||>Description||>Snippet||>Link To Document|